• menu

    BLOG

    MARKET INTEL by PharmaCompass

    CONTENT by Suppliers

    News

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
    4-[[(2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)oxolane-2-carbonyl]amino]pyridine-2-carboxamide
    |
    Stock Recap #PipelineProspector

    Pipeline Prospector Jan 2025: J&J’s US$ 14.6 bn Intra-Cellular buyout kicks off deal frenzy; Ozempic clinches FDA nod for CKD

    January was a busy month that saw several deals being announced at the JP Morgan Healthcare Conferen
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.